Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor

Overview of attention for article published in Cancer (0008543X), October 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 51,800 followers.

Interesting data on dasatanib in specific subsets of sarcoma in @JournalCancer https://t.co/ckcI9aic31

#Dasatanib fails to control tumor growth in five #sarcoma subtypes, but may hold promise for subset of patients https://t.co/mKddg2ryw4 https://t.co/B7yrVx4NpV

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.